Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies. J of Skin [Internet]. 2019 Mar. 11 [cited 2025 Jun. 8];3(2):161. Available from: https://skin.dermsquared.com/skin/article/view/517